Asston Pharmaceuticals Ltd
Founded in 2019, Asston Pharmaceuticals Limited manufactures and exports pharmaceutical formulations and nutraceuticals under the "Asston" brand, utilizing a diversified business model that includes direct sales, contract manufacturing, and export primarily to African markets.
What Asston files
- Important29
- Others15
- Board Meeting12
- Dividend/Bonus3
- Insider Trading3
- Insider Trade1
7th Annual Report of Asston Pharmaceuticals Limited for the Financial Year 2025-26.
Notice of 7th Annual General Meeting scheduled to be held on 29th September, 2026 at 12:30 P.M.
Asston Pharmaceuticals' Board has approved the allotment of 2.41 Cr equity shares at Rs. 115 each, including a premium of Rs. 105. This preferential issue was made to 15 investors. Following this allotment, the company's paid-up equity share capital has increased to Rs. 10.92 Cr, comprising 1.09 Cr shares of...
Allotment of 24,10,431 equity shares via Preferential Allotment
Asston Pharmaceuticals' board has approved several key corporate actions. This includes appointing M/s Yash A. Jain & Associates as Internal Auditor and M/s Panchal S K & Associates as Statutory Auditors. The board also proposes the re-appointment of Mr. Ashish Narayan Sakalkar as Managing Director, subject to shareholder approval. Additionally,...